Find a Trial
Trial Summary
| Protocol No. | CTO-TAK-981-1503 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Abonour, Rafat | ||
| Scope | National | ||
| Phase | Phase I/II | ||
| Age Group | Adult | ||
| Title | A Phase 1b/2 Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of TAK-981 in Combination With Monoclonal Antibodies in Adult Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| Applicable Disease Sites | Multiple Myeloma | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Phone: (317) 278-5632 Email: iutrials@iu.edu | ||